Search

Learn about MSK Kids patient Rihanna, who was born with a cancer caused by an NTRK gene mutation and received the targeted therapy larotrectinib.

… Wednesday, September 7, 2022 The first day of kindergarten is a big day for every child’s family. But for Ana, it’s a day she worried would never come. Her daughter, Rihanna, has been a patient at Memorial Sloan Kettering Cancer Center (MSK) since she was a baby. Her groundbreaking treatment made history

The revised scoring system incorporates molecular information related to 31 genes to help predict risk.

… Monday, June 13, 2022 A new molecular scoring system promises to improve the treatment of a set of blood cancers called myelodysplastic syndromes (MDS) , according to an international team of researchers. The findings were announced June 12, 2022 at the European Hematology Association conference in Vienna

Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.

… Thursday, September 26, 2024 Rachel Samuels Rand (l) with her husband, Brendan Rand. Rachel Samuels Rand (l) with her husband, Brendan Rand. After a double mastectomy performed at Memorial Sloan Kettering, Rachel got realistic 3-D nipple and areola tattoos by MSK specialist Alicia Jones. Rachel says

A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at diagnosis. The results enabled doctors to select the most appropriate drug designed to block the identified mutation and choose other treatment options for those patients whose tumors did not have a mutation.

… Saturday, June 4, 2011 Screening tumor samples for cancer-causing genetic mutations can help physicians tailor treatment to specifically target those mutations in patients with advanced lung cancer . A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at

Read a Q & A with Lucy Kalanithi, the widow of Paul Kalanithi, who wrote When Breath Becomes Air.

… Friday, February 3, 2017 Summary Lucy Kalanithi shared her experience as a caregiver for her husband, Paul, a neurosurgeon and author who passed away from lung cancer in March 2015. Lucy Kalanithi already had tears in her eyes as she took the stage before hundreds of MSK employees on February 2. Just

Despite the enormity of a terminal cancer diagnosis, finding a sense of meaning and joy in the final stages of life is possible. MSK ICU Nurse, Natassia Singh, took part in a one-hour panel discussion focusing on the challenges and gifts of end of life clinical care.

… Friday, October 23, 2020 Despite the enormity of a terminal cancer diagnosis, finding a sense of meaning and joy in the final stages of life is possible. For many people, this can be a difficult and frightening place to be but finding and maintaining peace at the end of life can open opportunities to

Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.

… Wednesday, September 22, 2021 Zhongmin Wang , a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2021 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Louis

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).

… Thursday, May 28, 2020 Dr. Charles Rudin Dr. Charles Rudin At the American Society of Clinical Oncology (ASCO) Virtual Scientific Program , Memorial Sloan Kettering (MSK) Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD , will present a study that found pembrolizumab addition to first-line

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

… Monday, December 1, 2014 Summary Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture. Since the late 1990s, when researchers first reported a technique to isolate and grow human embryonic stem cells, known as ES cells, in culture

Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.

… Thursday, October 1, 2020 Memorial Sloan Kettering is committed to having conversations about discrimination, diversity, and inclusion, and creating change. People from across MSK share their personal experiences and insights. Louis Voigt Louis Voigt LOUIS VOIGT Associate Attending Department of Anesthesiology